Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Arcus Biosciences Inc
(NY:
RCUS
)
16.31
-0.44 (-2.63%)
Streaming Delayed Price
Updated: 1:53 PM EDT, May 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Arcus Biosciences Inc
< Previous
1
2
3
4
5
Next >
Stock Market Rally Broadens Out; Apple Unveils Vision Pro, SEC Sues Binance, Coinbase: Weekly Review
June 09, 2023
The Nasdaq held near 52-week highs while small caps ramped up.
Via
Investor's Business Daily
ImmunoGen, Day One Surge On Cancer Drug Updates, But Arcus Crashes
June 05, 2023
ImmunoGen and Day One gained Monday on their updates at a cancer treatment conference.
Via
Investor's Business Daily
3 Undervalued Biotech Stocks to Buy Before They Blast Off
June 02, 2023
Fundamental analysis makes these three undervalued biotech stocks to buy plus they have other catalysts that make them compelling.
Via
InvestorPlace
12 Health Care Stocks Moving In Monday's Pre-Market Session
May 29, 2023
Via
Benzinga
Citigroup Maintains Buy Rating for Arcus Biosciences: Here's What You Need To Know
May 26, 2023
Via
Benzinga
Earnings Preview For Arcus Biosciences
May 08, 2023
Via
Benzinga
Arcus Biosciences Earnings Perspective: Return On Capital Employed
March 06, 2023
Via
Benzinga
Where Arcus Biosciences Stands With Analysts
December 20, 2022
Via
Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
May 26, 2023
Via
Benzinga
Why Hibbett Shares Are Trading Lower By 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session
May 26, 2023
Gainers Onfolio Holdings, Inc. (NASDAQ: ONFO) gained 73% to $2.02 after the company announced it completed development of a generative AI search tool.
Via
Benzinga
Booz Allen Hamilton, Workday, Marvell Technology And Other Big Stocks Moving Higher On Friday
May 26, 2023
U.S. stocks traded higher, with the Dow Jones gaining over 300 points on Friday. Here are some big stocks recording gains in today’s session.
Via
Benzinga
Arcus Biosciences Soars On Roche's 'Meaningful' Results In A New Cancer Drug Class
May 26, 2023
Roche tested its treatment in patients with liver cancer and found "meaningful" results.
Via
Investor's Business Daily
Nasdaq Rises 1%; US Goods Trade Gap Widens In April
May 26, 2023
U.S. stocks traded higher this morning, with the Nasdaq Composite gaining around 1% on Friday. Following the market opening Friday, the Dow traded up 0.87% to 33,050.97 while the NASDAQ rose 1.06% to...
Via
Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
May 26, 2023
Via
Benzinga
Why Gap Shares Are Trading Higher By 12%; Here Are 20 Stocks Moving Premarket
May 26, 2023
Gainers Oncorus, Inc. (NASDAQ: ONCR) shares rose 90% to $0.38 in pre-market trading after dropping around 17% on Thursday. Oncorus recently posted a narrower-than-expected quarterly loss.
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
May 26, 2023
It's time for another dive into the biggest pre-market stock movers as we check out what's happening this morning on Friday!
Via
InvestorPlace
3 Analyst Upgrades That Smart Investors Won’t Ignore
May 17, 2023
In many cases, analyst upgrades can point investors to opportunities like the ones in the stocks on this list.
Via
InvestorPlace
Can The No. 1 Pharma Stock, Merck, Continue Its Blazing Run In 2023?
January 05, 2023
Merck has a number of efforts in the works to help avoid a Keytruda generics pitfall.
Via
Investor's Business Daily
Stock Market Falls Sharply Again As Tesla Dives, Micron Hits Chips; Nike, FedEx Strong: Weekly Review
December 23, 2022
The market uptrend is under pressure.
Via
Investor's Business Daily
Earnings Scheduled For February 28, 2023
February 28, 2023
Companies Reporting Before The Bell • Gaotu Techedu (NYSE:GOTU) is expected to report earnings for its fourth quarter.
Via
Benzinga
Gilead Sciences (GILD) Stock Falls on Lung Cancer Drug Data
December 20, 2022
Although Gilead Sciences produced meaningful results regarding a lung cancer drug test, the competitive shortfall hurt GILD stock.
Via
InvestorPlace
Dow Jumps 150 Points; Crude Oil Rises 1%
December 20, 2022
U.S. stocks traded higher toward the end of trading, with the Dow Jones gaining around 150 points on Tuesday.
Via
Benzinga
Why IceCure Medical Shares Are Trading Higher By 296%? Here Are 64 Stocks Moving In Tuesday's Mid-Day Session
December 20, 2022
Gainers IceCure Medical Ltd (NASDAQ: ICCM) shares jumped 296% to $3.71 after the company announced interim results from the ICESECRET study for the treatment of patients with small renal masses who...
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
December 20, 2022
Via
Benzinga
Nasdaq Edges Lower; Gold Rises 1.5%
December 20, 2022
U.S. stocks traded mixed midway through trading, with the S&P 500 and the Nasdaq Composite moving lower on Tuesday.
Via
Benzinga
Arcus Biosciences, FuelCell Energy And Some Other Big Stocks Moving Lower On Tuesday
December 20, 2022
U.S. stocks traded higher, with the Dow Jones gaining over 100 points on Tuesday. Here are some big stocks recording losses in today’s session.
Via
Benzinga
Arcus, Gilead Disappoint As Lung-Cancer Regimen Lags Rival Roche
December 20, 2022
Gilead and Arcus toppled Tuesday after their lung-cancer regimen trailed a rival concoction from Roche.
Via
Investor's Business Daily
US Stocks Edge Higher; Dow Rises 50 Points
December 20, 2022
U.S. stocks traded mostly higher this morning, with the Dow Jones gaining around 50 points on Tuesday.
Via
Benzinga
Gilead-Arcus Partnered Domvanalimab Combo Study Show Improved Progression-Free Survival In Lung Cancer Patients
December 20, 2022
Via
Benzinga
Gilead's Cancer Program Notches Another Win, But It's Arcus Stock That Surges
November 28, 2022
Gilead and Arcus notched another win for their cancer program on Monday. GILD stock briefly hit a four-year high as RCUS stock gapped higher.
Via
Investor's Business Daily
< Previous
1
2
3
4
5
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.